NCT02468050

Brief Summary

The breast cancer screening and diagnostic period is associated with heightened symptoms of anxiety and depression. Physical exercise has been found to effectively decrease these symptoms in healthy and diseased populations. This study aims to determine if a pre treatment exercise intervention can minimize symptoms of anxiety and depression in women undergoing screening for breast cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for phase_2 breast-cancer

Timeline
Completed

Started Feb 2012

Shorter than P25 for phase_2 breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 25, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
1.4 years until next milestone

First Posted

Study publicly available on registry

June 10, 2015

Completed
Last Updated

June 10, 2015

Status Verified

June 1, 2015

Enrollment Period

2 years

First QC Date

June 25, 2012

Last Update Submit

June 5, 2015

Conditions

Keywords

AnxietyDepressionExerciseBreast CancerBiopsyScreeningDiagnosis

Outcome Measures

Primary Outcomes (1)

  • Symptoms of anxiety will be assessed using patient reported anxiety inventory

    Spielberger State-Trait Anxiety Inventory - State Form (STAI; Spielberger, Gorsuch, \& Lushene, 1970).

    Change in baseline (within 1 week of breast biopsy) at Week 3 and at Week 6

Secondary Outcomes (6)

  • Symptoms of subclinical depression will be assessed using a patient reported inventory

    Within 1 week of breast biopsy, Week 3, Week 6

  • Exercise behaviour will be assessed using a patient reported inventory

    Within 1 week of breast biopsy, Week 3, Week 6

  • Body composition: Dual X-Ray Absorptiometry scan (GE Lunar iDXA)

    Baseline (within 1 week of breast biopsy), Week 6

  • Self Efficacy: patient reported inventory assessing efficacy for self management of exercise

    1 week post breast biopsy, Week 3, Week 6

  • Optimism: patient reported inventory assessing dispositional optimism

    Baseline (within 1 week of core breast biopsy)

  • +1 more secondary outcomes

Study Arms (3)

Self Management

EXPERIMENTAL

In addition to the weekly supervised exercise session, participants in this arm will view an instructional video. The video will deliver theory driven training of cognitive behavioural strategies for self management of exercise. It is expected that this will improve adherence to the exercise program.

Behavioral: Moderate intensity exercise trainingBehavioral: Self Management of exercise

Exercise

EXPERIMENTAL

Personalized 6 week moderate intensity (50 - 75% of heart rate reserve) facility and home based exercise program including cardiovascular and muscular conditioning.

Behavioral: Moderate intensity exercise training

Prospective Cohort Control

NO INTERVENTION

Eligible, consented participants who are unable to attend the weekly exercise sessions will serve as a cohort control group. Participants will be asked to complete patient reported measures of anxiety, depression, and exercise behaviour within 3 days of biopsy, and 6 weeks post biopsy.

Interventions

6 weeks of moderate intensity exercise training (50 - 75% of heart rate reserve). Sessions are facility and home based and include cardiovascular warm-up, cardiovascular training, muscular conditioning, and flexibility exercises.

Also known as: Exercise, Treatment Group 1
ExerciseSelf Management

In addition to the 6 week exercise program (refer to Exercise Treatment Group), participants randomly assigned to the Self Management Group will learn strategies for the self management of exercise.

Also known as: Self Management, Self Regulation, Adherence, Treatment Group 2
Self Management

Eligibility Criteria

Age18 Years - 69 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • undergoing breast biopsy at St. Joseph's Health Care, London Ontario
  • minimum BI-RADS 4a
  • physically inactive

You may not qualify if:

  • meeting Health Canada Guidelines for Physical Activity for past 6 months
  • medical contraindications to exercise
  • unable to participate in moderate intensity exercise program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Exercise and Health Psychology Laboratory, Western University

London, Ontario, N6A 3K7, Canada

Location

MeSH Terms

Conditions

Breast NeoplasmsAnxiety DisordersDepressionMotor ActivityDisease

Interventions

ExerciseSelf-ManagementProfessional Autonomy

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesMental DisordersBehavioral SymptomsBehaviorPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaRehabilitationHealth ServicesHealth Care Facilities Workforce and ServicesProfessional PracticeOrganization and AdministrationHealth Services Administration

Study Officials

  • Muriel Brackstone, MD PhD FRCSC

    London Regional Cancer Program

    STUDY DIRECTOR
  • Anita G Cramp, PhD

    Western University

    STUDY DIRECTOR
  • Amy Kossert, MHK

    Western University

    STUDY DIRECTOR
  • Harry Prapavessis, PhD

    Western University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2012

First Posted

June 10, 2015

Study Start

February 1, 2012

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

June 10, 2015

Record last verified: 2015-06

Locations